Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|August 17, 2019
Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen PresentationMohammed O Abdelaziz, Sophia Ossmann, Andreas M Kaufmann, et al.
Nature Communications|July 15, 2026
Oncogene inactivation-induced senescence facilitates tumor relapsePhilipp Schmitt, Katrin Hönig, Maria Teresa Norcia, et al.
The Journal of Experimental Medicine|June 5, 2002
Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reactionZhihai Qin, Hye-Jung Kim, Jens Hemme, et al.
The Journal of Clinical Investigation|December 12, 2018
Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regressionLucia Poncette, Xiaojing Chen, Felix Km Lorenz, et al.
JCI Insight|April 28, 2022
EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in miceArmin Rehm, Anthea Wirges, Dana Hoser, et al.
Nature Reviews. Cancer|March 2, 2012
The determinants of tumour immunogenicityThomas Blankenstein, Pierre G Coulie, Eli Gilboa, et al.
International Journal of Cancer|January 4, 2012
B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin)Thomas Kammertoens, Zhihai Qin, Dana Briesemeister, et al.
Thyroid : Official Journal of the American Thyroid Association|November 19, 2020
Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient BloodHeidrun Degen, Ioannis Gavvovidis, Thomas Blankenstein, et al.
Plos One|July 23, 2016
Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host CellsKatrin Deiser, Diana Stoycheva, Ute Bank, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2008
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferElisa Kieback, Jehad Charo, Daniel Sommermeyer, et al.
Pageof 15